Microfluidic model with air-walls reveals fibroblasts and keratinocytes modulate melanoma cell phenotype, migration, and metabolism.


Journal

Lab on a chip
ISSN: 1473-0189
Titre abrégé: Lab Chip
Pays: England
ID NLM: 101128948

Informations de publication

Date de publication:
21 03 2021
Historique:
pubmed: 4 2 2021
medline: 22 6 2021
entrez: 3 2 2021
Statut: ppublish

Résumé

Melanoma evolution is a complex process. The role epidermal keratinocytes and dermal fibroblasts play in this process and the mechanisms involved in tumor-stroma interactions remain poorly understood. Here, we used a microfluidic platform to evaluate the cross-talk between human primary melanoma cells, keratinocytes and dermal fibroblasts. The microfluidic device included multiple circular chambers separated by a series of narrow connection channels. The microdevice design allowed us to develop a new cell patterning method based on air-walls, removing the need for hydrogel barriers, porous membranes, or external equipment. Using this method, we co-cultured melanoma cells in the presence of keratinocytes and/or dermal fibroblasts. The results demonstrated that the presence of dermal fibroblasts and keratinocytes led to changes in melanoma cell morphology and growth pattern. Molecular analysis revealed changes in the chemokine secretion pattern, identifying multiple secreted factors involved in tumor progression. Finally, optical metabolic imaging showed that melanoma cells, fibroblasts, and keratinocytes exhibited different metabolic features. Additionally, the presence of stromal cells led to a metabolic shift in melanoma cells, highlighting the role the skin microenvironment on melanoma evolution.

Identifiants

pubmed: 33533390
doi: 10.1039/d0lc00988a
pmc: PMC7990711
mid: NIHMS1670175
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1139-1149

Subventions

Organisme : NCI NIH HHS
ID : R01 CA205101
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA211082
Pays : United States

Références

Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:338-41
pubmed: 26736268
Br J Cancer. 2015 May 26;112(11):1772-81
pubmed: 25942396
Mol Pharm. 2011 Dec 5;8(6):2039-49
pubmed: 22067046
Lab Chip. 2019 Oct 9;19(20):3461-3471
pubmed: 31506657
Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):214-9
pubmed: 25524628
Lab Chip. 2018 Dec 7;18(23):3687-3702
pubmed: 30393802
FASEB J. 2014 Nov;28(11):4583-90
pubmed: 25077562
Nat Methods. 2016 Feb;13(2):151-7
pubmed: 26689262
Oncogene. 2017 Oct 19;36(42):5771-5792
pubmed: 28604751
EBioMedicine. 2018 Nov;37:144-157
pubmed: 30482722
Lab Chip. 2015 Jan 7;15(1):301-10
pubmed: 25370780
Nat Rev Drug Discov. 2010 Jul;9(7):503-4
pubmed: 20592733
Cell Prolif. 1996 Jun;29(6):315-23
pubmed: 8809123
Int J Mol Sci. 2018 Jul 24;19(8):
pubmed: 30042333
Cancer Res. 2014 Sep 15;74(18):5184-94
pubmed: 25100563
Cancer Metab. 2016 Aug 18;4:16
pubmed: 27540483
Chem Soc Rev. 2020 Sep 1;49(17):6402-6442
pubmed: 32760967
Melanoma Res. 2010 Oct;20(5):372-80
pubmed: 20700063
Pigment Cell Res. 2007 Jun;20(3):161-72
pubmed: 17516924
Integr Biol (Camb). 2015 Jun;7(6):643-54
pubmed: 25998180
Cancer Res. 2013 Oct 15;73(20):6164-74
pubmed: 24130112
Sci Rep. 2017 Dec 22;7(1):18071
pubmed: 29273771
Micromachines (Basel). 2019 Oct 07;10(10):
pubmed: 31591365
Int J Cancer. 2010 Oct 1;127(7):1625-36
pubmed: 20099279
Cell Mol Immunol. 2018 Apr;15(4):335-345
pubmed: 29375123
PLoS One. 2015 Oct 07;10(10):e0139515
pubmed: 26444904
Lab Chip. 2017 Jan 31;17(3):511-520
pubmed: 28092382
JCI Insight. 2017 Jun 15;2(12):
pubmed: 28614795
J Cancer. 2015 Jun 23;6(8):717-26
pubmed: 26185533
Integr Biol (Camb). 2013 Sep;5(9):1119-29
pubmed: 23644926
Anticancer Res. 2015 Jun;35(6):3537-41
pubmed: 26026122
Free Radic Biol Med. 2016 Nov;100:53-65
pubmed: 27519271
Am J Pathol. 2012 Jan;180(1):365-74
pubmed: 22037251
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1271-5
pubmed: 1741380
Nat Biomed Eng. 2019 Jul;3(7):520-531
pubmed: 31086325
Cancer Res. 2004 Jun 1;64(11):4010-7
pubmed: 15173015
Cancer Cell. 2013 May 13;23(5):706-706.e1
pubmed: 23680152
J Cell Commun Signal. 2016 Sep;10(3):191-196
pubmed: 27553358
Nature. 2014 Mar 13;507(7491):181-9
pubmed: 24622198
Mol Ther. 2004 Jun;9(6):846-55
pubmed: 15194051
Melanoma Res. 2012 Oct;22(5):327-33
pubmed: 22713796

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH